ctrl K

Price Alert

Rigel Pharmaceuticals Inc... (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

40.08

0.57 (1.44%)

At close: Aug 18, 2025, 3:59 PM

40.07

-0.01%

Pre-market: Aug 19, 2025, 04:33 AM EDT

Rigel Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	56.75M	32.79M	24.46M	18.89M
Short-Term Investments	20.57M	24.15M	33.75M	106.08M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.44M	3.06M	640K	974K
Receivables	41.62M	30.55M	40.32M	15.47M
Inventory	6M	5.52M	9.12M	6.62M
Other Current Assets	10.16M	6.26M	8.26M	7.41M
Total Current Assets	135.1M	99.27M	115.9M	154.47M
Property-Plant & Equipment	338K	1.03M	2.79M	11.89M
Goodwill & Intangibles	27.1M	13.88M	14.95M	n/a
Total Long-Term Assets	28.87M	17.96M	18.38M	12.86M
Total Assets	163.98M	117.22M	134.28M	167.33M
Account Payables	3.34M	7.14M	22.51M	3.79M
Deferred Revenue	1.35M	1.35M	13.51M	2.6M
Short-Term Debt	7.56M	7.92M	1.13M	9.89M
Other Current Liabilities	51.05M	27.31M	24.88M	26.69M
Total Current Liabilities	63.3M	53.27M	65.21M	63.55M
Long-Term Debt	52.41M	52.37M	39.45M	19.91M
Other Long-Term Liabilities	44.98M	39.94M	42.26M	52.73M
Total Long-Term Liabilities	97.39M	92.6M	82.68M	73.4M
Total Liabilities	160.69M	145.87M	147.9M	136.95M
Total Debt	59.97M	60.58M	41.55M	30.57M
Common Stock	18K	175K	174K	172K
Retained Earnings	-1.39B	-1.41B	-1.38B	-1.32B
Comprehensive Income	10K	8K	-153K	-102K
Shareholders Equity	3.29M	-28.64M	-13.62M	30.37M
Total Investments	20.57M	24.15M	33.75M	106.08M